EFX vs LXEO · P/E 54, rev $3.35B vs $147.7M cap
Equifax Inc (EFX) versus Lexeo Therapeutics, Inc. Common Stock (LXEO) — a side-by-side from cached financials, not a winner call.
Equifax Inc (EFX) is a consulting services company listed on US.
Lexeo Therapeutics, Inc. Common Stock (LXEO) is a biotechnology company listed on US.
Latest reported EFX revenue for 2026-06-30 was $3.35B. Net income was $355.4M. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
LXEO does not have a complete income-statement cache yet.
EFX currently screens at market cap $33.00B and trailing P/E 54.0. LXEO currently screens at market cap $147.7M.
Not investment advice. Open the EFX and LXEO stock pages for the full models.
Not investment advice.